Feng Xie is a Professor of Health Economics in the Department of Health Research Methods, Evidence and Impact (HEI) and a member of the Centre for Health Economics and Policy Analysis. His research interests include health technology assessment, economic evaluations using models and trial data, patient-reported outcome and preference measures, and health utility measures. Xie is deputy editor-in-chief of the BMC Journal: Health and Quality of Life Outcomes  and an associated editor of Medical Decision Making . He received a Career Scientist Award from Ontario Ministry of Health and Long Term Care and a Canadian Institutes of Health Research (CIHR) New Investigator Award. Xie has been involved in numerous HTA and economic evaluations in assessing new health technologies to support national and provincial reimbursement decision-making. He is also interested in measuring patient-reported outcomes in the context of clinical trials and economic evaluations. He holds a PhD in pharmacoeconomics and outcomes research from the National University of Singapore; an MSc in pharmacy administration from Fudan University and a BSc in pharmacy from Shanghai Medical University.